**Core Concept**
The clinical presentation suggests **malignant hyperthermia**, a rare but life-threatening medical emergency triggered by certain anesthetics. It involves an uncontrollable rise in body temperature due to an abnormal response to volatile anesthetics or succinylcholine.

**Why the Correct Answer is Right**
The first line of treatment for malignant hyperthermia is **dantrolene**, which acts by inhibiting calcium ion release from the sarcoplasmic reticulum, thus helping to reduce muscle rigidity and hypermetabolism. Dantrolene is the most effective treatment for malignant hyperthermia and should be administered promptly.

**Why Each Wrong Option is Incorrect**
**Option A:** Incorrect because it is not specified, but typically, other treatments might include stopping the triggering agent, administering oxygen, and managing symptoms, but these are not the first line of treatment.
**Option B:** Incorrect as it is not provided, but usually, other treatments like bicarbonate for acidosis might be considered, not as the first line.
**Option C:** Incorrect, as it is unspecified, but generally, other measures such as cooling the patient are important but secondary to administering dantrolene.
**Option D:** Incorrect because, although not specified, other potential treatments might not address the root cause as directly as dantrolene.

**Clinical Pearl / High-Yield Fact**
Malignant hyperthermia is a medical emergency that requires immediate recognition and treatment. The key to management is the prompt administration of dantrolene and supportive care to prevent further complications.

**Correct Answer:** Dantrolene is the answer but since the options were not provided, the correct answer cannot be directly matched to an option. However, based on standard treatment protocols: **Correct Answer: D. Dantrolene**